Laurus Labs Limited
Records under this name other than the patents Laurus Labs Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 27 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,603,382 | Diastereoselective Synthesis of Phosphate Derivatives Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,434,196 | Process for Preparation of 2-Amino-5-Hydroxy Propiophenone Lapsed on the fee record Ended Sep 6, 2026 · High confidence | Lapsed on the fee record | Ended Sep 6, 2026 | High confidence |
| US 11,427,555 | Novel Processes for Preparation of Dapagliflozin or Its Solvates or Co-Crystals Thereof Lapsed on the fee record Ended Aug 30, 2026 · High confidence | Lapsed on the fee record | Ended Aug 30, 2026 | High confidence |
| US 11,427,570 | Process for the Preparation of Pazopanib or a Pharmaceutically Acceptable Salt Thereof Lapsed on the fee record Ended Aug 30, 2026 · High confidence | Lapsed on the fee record | Ended Aug 30, 2026 | High confidence |
| US 11,414,386 | Process for the Preparation of Ivacaftor and Its Itermediates Lapsed on the fee record Ended Aug 16, 2026 · High confidence | Lapsed on the fee record | Ended Aug 16, 2026 | High confidence |
| US 8,791,259 | Process for the Preparation of Tenofovir Lapsed on the fee record Ended Jul 29, 2026 · High confidence | Lapsed on the fee record | Ended Jul 29, 2026 | High confidence |
| US 11,345,684 | Process and crystalline forms of Lumacaftor Lapsed on the fee record Ended May 31, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 31, 2026 | From the USPTO record |
| US 11,345,685 | Process and crystalline forms of lumacaftor Lapsed on the fee record Ended May 31, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 31, 2026 | From the USPTO record |
| US 11,318,116 | Stable amorphous form of sacubitril valsartan trisodium complex and processes for preparation thereof Lapsed on the fee record Ended May 3, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 3, 2026 | From the USPTO record |
| US 9,957,234 | Polymorphs of Ivacaftor, process for its preparation and pharmaceutical composition thereof Lapsed on the fee record Ended May 1, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 1, 2026 | From the USPTO record |